Ductal Carcinoma In Situ: Treatment, Survival, and Lifestyle Tips - Oncology

Share to:

Ductal Carcinoma In Situ (DCIS)


Hello, my family member was recently diagnosed with ductal carcinoma in situ (DCIS).
I would like to ask if this is considered cancer? What is the cure rate? Does "cure" mean complete recovery? What dietary, nutritional, and lifestyle changes should we be aware of moving forward? It is difficult for the patient, and it is also hard for the family.
What should I pay attention to in supporting the patient? I have found various information on other websites, but I hope to get clear answers.
Thank you.

PAC, 20~29 year old female. Ask Date: 2013/12/12

Dr. Chen Sirong reply Oncology


Hello: 1.
Is this cancer? A: Yes, it is cancer, but some insurance plans do not cover well-treatable in situ cancers.
2.
Is the cure rate high? A: If proper treatment is received, the ten-year survival rate can reach ninety-five percent.
3.
Does cure mean complete recovery? A: That depends on your definition of recovery.
I believe that for this in situ cancer, it can be considered cured; however, 3.1 as long as not all of the affected breast tissue is removed, the risk of developing cancer in other parts remains higher than average.
3.2 If one has had cancer in one breast, the other breast is also at a higher risk of developing cancer compared to the general population.
4.
Regarding diet and nutritional supplements: A: A normal diet is sufficient; antioxidant-rich fruits and vegetables of various colors are excellent, but do not force the patient.
5.
What lifestyle habits should be monitored? A: A normal lifestyle is sufficient; do not force the patient to exercise.
Yoga and exercise that induce sweating can release natural endorphins, making everyone feel happier, which is beneficial for all.
6.
What should be monitored for the patient? A: Some breast cancer patients may originally have a Type C personality; helping them to be more cheerful and manage stress is an important topic.
Wishing for a speedy recovery, Dr.
Chen Sih-Jung, Taoyuan Hospital.

Reply Date: 2013/12/12

More Info


Ductal Carcinoma In Situ (DCIS) is a non-invasive form of breast cancer that is often detected through mammograms. It is characterized by the presence of abnormal cells in the ducts of the breast, but these cells have not spread beyond the ducts into the surrounding breast tissue. While it is classified as breast cancer, it is important to note that DCIS is not life-threatening in the same way that invasive breast cancers can be.

Understanding DCIS
1. Is DCIS Cancer?
Yes, DCIS is considered a form of breast cancer, but it is non-invasive. This means that while the cells are abnormal and have the potential to become invasive, they have not yet spread beyond the ducts. Early detection and treatment are crucial in managing DCIS effectively.

2. Survival Rates and Cure
The prognosis for DCIS is generally very good. The five-year survival rate for women diagnosed with DCIS is nearly 100% when treated appropriately. Treatment options typically include surgery (lumpectomy or mastectomy), and in some cases, radiation therapy may be recommended to reduce the risk of recurrence. The term "cure" in the context of DCIS often refers to the successful removal of the abnormal cells and the prevention of future invasive cancer.
3. Lifestyle and Dietary Considerations
After a diagnosis of DCIS, it is essential to adopt a healthy lifestyle to support overall well-being and potentially reduce the risk of recurrence. Here are some tips:
- Nutrition: Focus on a balanced diet rich in fruits, vegetables, whole grains, and lean proteins. Antioxidant-rich foods may help combat oxidative stress in the body.

- Weight Management: Maintaining a healthy weight is crucial, as obesity can increase the risk of breast cancer recurrence.

- Physical Activity: Regular exercise is beneficial for overall health and can help manage weight. Aim for at least 150 minutes of moderate aerobic activity each week.

- Limit Alcohol: Studies suggest that alcohol consumption may increase the risk of breast cancer. Limiting intake to one drink per day or less is advisable.

- Avoid Tobacco: Smoking is linked to a higher risk of various cancers, including breast cancer. Quitting smoking can significantly improve health outcomes.

4. Emotional Support for Patients and Families
A cancer diagnosis can be emotionally taxing not only for the patient but also for family members. Here are some ways to provide support:
- Open Communication: Encourage open discussions about feelings, fears, and concerns. Being a good listener can help the patient feel understood and supported.

- Encourage Professional Help: If the emotional burden becomes overwhelming, suggest seeking help from a mental health professional or joining a support group.

- Participate in Care: Offer to accompany the patient to appointments or help with daily tasks. This can alleviate some stress and show that you are there for them.

- Educate Yourself: Understanding DCIS and its treatment options can empower both the patient and family members. Knowledge can help alleviate fears and uncertainties.

5. Follow-Up Care
Regular follow-up appointments are essential after treatment for DCIS. These visits typically include physical exams and mammograms to monitor for any signs of recurrence. Discuss any changes in health or new symptoms with the healthcare provider promptly.

In summary, while a diagnosis of DCIS can be concerning, it is important to remember that it is a non-invasive cancer with a high survival rate when treated appropriately. Adopting a healthy lifestyle, providing emotional support, and maintaining open communication can significantly benefit both the patient and their loved ones during this challenging time. Always consult with healthcare professionals for personalized advice and treatment options.

Similar Q&A

Understanding Ductal Carcinoma In Situ: Diagnosis, Treatment, and Monitoring

Hello Dr. Chou, At the end of last year, I discovered a hard lump in my breast. I went to Shin Kong Wu Ho-Su Memorial Hospital for examination and biopsy, and the report indicated it was benign. The doctor advised me not to undergo surgery and to just monitor it. However, due to...


Dr. Zhou Jiazhen reply Breast and Thyroid
Dear Candy, 1. Ultrasound has a higher diagnostic rate for palpable lumps. If there is suspicion, a core needle biopsy is recommended. If the result is benign, surgical removal of the tumor or short-term follow-up is suggested (if there is suspicion from ultrasound or physical e...

[Read More] Understanding Ductal Carcinoma In Situ: Diagnosis, Treatment, and Monitoring


Understanding DCIS: Treatment Options and Controversies for Early-Stage Breast Cancer

Hello, this year during a mammogram, some calcifications were found in the right breast. After undergoing breast ultrasound and biopsy, it was determined to be DCIS (Ductal Carcinoma In Situ). Since the lesion is smaller than 1 cm and has not invaded beyond the ducts, and I don&#...


Dr. Zhou Jiazhen reply Breast and Thyroid
Dear Hommie: 1. Ductal Carcinoma In Situ (DCIS) is classified as a non-invasive breast cancer, with statistics indicating that approximately 30% may progress to invasive breast cancer within 5 to 10 years. 2. Knowing that one has DCIS and the associated risk of malignant prog...

[Read More] Understanding DCIS: Treatment Options and Controversies for Early-Stage Breast Cancer


Understanding HER2-Positive Ductal Carcinoma In Situ with Microinvasion

Hello, Doctor! The pathology report for breast cancer is as follows: Ductal carcinoma in situ, high-grade, suspicious for microinvasive carcinoma, Pathological TNM Staging (in conjunction with ST22-05037): pT1mi pN0(sn) pMX, ER: Negative (0%), PR: Negative (0%), HER2: Positive (s...


Dr. Chen Yunfang reply Oncology
Hello: 1. Yes, it is stage one. 2. This cannot be answered as your description lacks sufficient information, and I am not your attending physician, so I cannot provide a substitute answer. Thank you.

[Read More] Understanding HER2-Positive Ductal Carcinoma In Situ with Microinvasion


Understanding HER2 Testing in Ductal Carcinoma In Situ: What You Need to Know

Hello, Doctor. I was diagnosed with breast cancer on July 28, 2022, through a core needle biopsy, and I underwent a partial mastectomy with sentinel lymph node surgery on August 19. The subsequent pathology report indicated that it is ductal carcinoma in situ (DCIS), with positiv...


Dr. Yuan Tianmin reply Breast and Thyroid
The HER-2 or Ki-67 expression in in situ carcinoma does not serve as a reference for treatment, which is why some hospitals may not test for these markers. However, this should not affect your subsequent treatment.

[Read More] Understanding HER2 Testing in Ductal Carcinoma In Situ: What You Need to Know


Related FAQ

Bile Duct Cancer

(Oncology)

Pancreatic Cancer

(Oncology)

Cancer Treatment

(Oncology)

Breast Adenoma

(Oncology)

Lymph Node Cancer

(Oncology)

Uterus

(Oncology)

Neck Mass

(Oncology)

Melanoma

(Oncology)

Esophageal Cancer

(Oncology)

Axillary Lump

(Oncology)